Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years

Journal of the Medical Association of Thailand

Volumn 90, Issue 9, 2007, Pages 1715-1719

  Boonyarangkul, Arthit ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cycle control; Transdermal contraceptive patch

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; MENSTRUAL CYCLE; MENSTRUATION; NAUSEA; NORMAL HUMAN; ORAL CONTRACEPTION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPOTTING; STATISTICAL SIGNIFICANCE; THAILAND; TRANSDERMAL PATCH; WEIGHT GAIN;

ADMINISTRATION, CUTANEOUS; ADULT; AGE FACTORS; CONTRACEPTIVE AGENTS; CONTRACEPTIVES, ORAL; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; MENSTRUAL CYCLE; PREGNANCY; THAILAND; TIME FACTORS;

EID: 35848962517     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Shaaban MM. The perimenopause and contraception. Maturitas 1996; 23: 181-92.
2. Burkman RT. The transdermal contraceptive system. Am J Obstet Gynecol 2004; 190(4 Suppl): S49-53.
3. Zieman M. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra). Fertil Steril 2002; 77(2 Suppl 2): S1-2.
4. Abrams LS, Skee D, Natarajan J, Wong FA. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 2002; 77(2 Suppl 2): S3-12.
5. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002; 77(2 Suppl 2): S13-8.
6. Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril 2002; 77(2 Suppl 2): S19-26.
7. Westhoff C. Contraception at age 35 years and older. Clin Obstet Gynecol 1998; 41: 951-7.
8. Mattsson LA, Bohnet HG, Gredmark T, Torhorst J, Hornig F, Huls G. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations. Obstet Gynecol 1999; 94: 61-5.
9. Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 2001; 285: 2347-54.
10. Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy GW. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001; 98(5 Pt 1): 799-805.
11. Suwanmalee O, Taneepanichskul S. A clinical study of transdermal contraceptive patch in Thai women. J Med Assoc Thai 2006; 89(Suppl 4): S1-4.